Linked Life Data

17336486

Source:http://linkedlifedata.com/resource/pubmed/id/17336486

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2007-4-27
pubmed:abstractText
A large number of immunomodulatory therapies has been evaluated in patients with severe sepsis and septic shock. Until recently, none of these treatments has ever demonstrated any benefit in terms of decreased mortality. Many biases could interfere with the results of these clinical trials linked to poor comprehension of immune response, pharmacological errors, selection bias, and mistakes in the evaluation of the patients and in the interpretation of the results. Based on these methodological flaws, the authors try to define directions for future clinical trials.
pubmed:language
fre
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1769-6623
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
26
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
363-9
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
[Critical analysis of noninflammatory treatments of sepsis: lessons learned from previous trials].
pubmed:affiliation
Département d'anesthésie-réanimation chirurgicale, CHU Bichat-Claude-Bernard, Assistance publique-Hôpitaux de Paris, université Paris-VII, 75018 Paris, France. philippe.montravers@bch.aphp.fr
pubmed:publicationType
Journal Article, English Abstract, Review